Cargando…
Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study
BACKGROUND: Despite revascularisation, a large proportion of acute coronary syndrome (ACS) patients continue to experience major adverse cardiovascular events (MACEs), which are worsened by diabetes mellitus (DM). Fibrinogen (FIB) is a risk factor for MACEs in coronary artery disease and often eleva...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480802/ https://www.ncbi.nlm.nih.gov/pubmed/31014348 http://dx.doi.org/10.1186/s12933-019-0858-5 |
_version_ | 1783413649599102976 |
---|---|
author | Zhang, Lisha Xu, Chenbo Liu, Junhui Bai, Xiaofang Li, Ruifeng Wang, Lijun Zhou, Juan Wu, Yue Yuan, Zuyi |
author_facet | Zhang, Lisha Xu, Chenbo Liu, Junhui Bai, Xiaofang Li, Ruifeng Wang, Lijun Zhou, Juan Wu, Yue Yuan, Zuyi |
author_sort | Zhang, Lisha |
collection | PubMed |
description | BACKGROUND: Despite revascularisation, a large proportion of acute coronary syndrome (ACS) patients continue to experience major adverse cardiovascular events (MACEs), which are worsened by diabetes mellitus (DM). Fibrinogen (FIB) is a risk factor for MACEs in coronary artery disease and often elevated in DM. However, the relationships between FIB, glucose metabolism (haemoglobin A1c [HbA1c] and fasting blood glucose [FBG]) and MACEs following percutaneous coronary intervention (PCI) in DM, non-DM or whole patients with ACS remains unknown. METHODS: A total of 411 ACS patients undergoing PCI were enrolled in this study. We compared baseline FIB levels between DM (n = 103) and non-DM (n = 308) patients and divided participants into three groups according to FIB level, i.e. FIB-L, FIB-M and FIB-H, to compare baseline characteristics and MACEs. Linear regression analysis of the relationship between glucose metabolism and FIB, Cox regression, survival and landmark analyses of MACEs were also performed over a median of 27.55 months of follow-up. RESULTS: Patients with DM had higher FIB levels than non-DM patients (3.56 ± 0.99 mg/dL vs. 3.34 ± 0.80 mg/dL, P < 0.05). HbA1c and FBG were significantly positively correlated with FIB in whole and DM patients but not in non-DM patients (all P < 0.05). Compared with the FIB-L group, the FIB-M (hazard ratio [HR] 1.797, 95% CI 1.117–2.892, P = 0.016) and FIB-H (HR 1.664, 95% CI 1.002–2.763, P = 0.049) groups were associated with higher MACEs in whole; the FIB-M (HR 7.783, 95% CI 1.012–59.854, P = 0.049) was associated with higher MACEs in DM patients. FIB was not associated with MACEs in non-DM patients. During landmark analysis, FIB showed better predictive value for MACEs after PCI in the first 30 months of follow up than in the subsequent period. CONCLUSION: In this study from China, FIB was positively associated with glucose metabolism (HbA1c and FBG) in whole and DM populations with ACS. Moreover, elevated baseline FIB levels may be an important and independent predictor of MACEs following PCI, especially amongst those with DM. However, as the follow-up period increased, the baseline FIB levels lost their ability to predict MACEs. |
format | Online Article Text |
id | pubmed-6480802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64808022019-05-01 Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study Zhang, Lisha Xu, Chenbo Liu, Junhui Bai, Xiaofang Li, Ruifeng Wang, Lijun Zhou, Juan Wu, Yue Yuan, Zuyi Cardiovasc Diabetol Original Investigation BACKGROUND: Despite revascularisation, a large proportion of acute coronary syndrome (ACS) patients continue to experience major adverse cardiovascular events (MACEs), which are worsened by diabetes mellitus (DM). Fibrinogen (FIB) is a risk factor for MACEs in coronary artery disease and often elevated in DM. However, the relationships between FIB, glucose metabolism (haemoglobin A1c [HbA1c] and fasting blood glucose [FBG]) and MACEs following percutaneous coronary intervention (PCI) in DM, non-DM or whole patients with ACS remains unknown. METHODS: A total of 411 ACS patients undergoing PCI were enrolled in this study. We compared baseline FIB levels between DM (n = 103) and non-DM (n = 308) patients and divided participants into three groups according to FIB level, i.e. FIB-L, FIB-M and FIB-H, to compare baseline characteristics and MACEs. Linear regression analysis of the relationship between glucose metabolism and FIB, Cox regression, survival and landmark analyses of MACEs were also performed over a median of 27.55 months of follow-up. RESULTS: Patients with DM had higher FIB levels than non-DM patients (3.56 ± 0.99 mg/dL vs. 3.34 ± 0.80 mg/dL, P < 0.05). HbA1c and FBG were significantly positively correlated with FIB in whole and DM patients but not in non-DM patients (all P < 0.05). Compared with the FIB-L group, the FIB-M (hazard ratio [HR] 1.797, 95% CI 1.117–2.892, P = 0.016) and FIB-H (HR 1.664, 95% CI 1.002–2.763, P = 0.049) groups were associated with higher MACEs in whole; the FIB-M (HR 7.783, 95% CI 1.012–59.854, P = 0.049) was associated with higher MACEs in DM patients. FIB was not associated with MACEs in non-DM patients. During landmark analysis, FIB showed better predictive value for MACEs after PCI in the first 30 months of follow up than in the subsequent period. CONCLUSION: In this study from China, FIB was positively associated with glucose metabolism (HbA1c and FBG) in whole and DM populations with ACS. Moreover, elevated baseline FIB levels may be an important and independent predictor of MACEs following PCI, especially amongst those with DM. However, as the follow-up period increased, the baseline FIB levels lost their ability to predict MACEs. BioMed Central 2019-04-23 /pmc/articles/PMC6480802/ /pubmed/31014348 http://dx.doi.org/10.1186/s12933-019-0858-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Zhang, Lisha Xu, Chenbo Liu, Junhui Bai, Xiaofang Li, Ruifeng Wang, Lijun Zhou, Juan Wu, Yue Yuan, Zuyi Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
title | Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
title_full | Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
title_fullStr | Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
title_full_unstemmed | Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
title_short | Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
title_sort | baseline plasma fibrinogen is associated with haemoglobin a1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480802/ https://www.ncbi.nlm.nih.gov/pubmed/31014348 http://dx.doi.org/10.1186/s12933-019-0858-5 |
work_keys_str_mv | AT zhanglisha baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT xuchenbo baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT liujunhui baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT baixiaofang baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT liruifeng baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT wanglijun baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT zhoujuan baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT wuyue baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy AT yuanzuyi baselineplasmafibrinogenisassociatedwithhaemoglobina1cand2yearmajoradversecardiovasculareventsfollowingpercutaneouscoronaryinterventioninpatientswithacutecoronarysyndromeasinglecentreprospectivecohortstudy |